drugset / Trial / NCT00115778
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
RandomizedCrossoverQuadruple-blindPrevention
Summary
The purpose of this study is to determine if intravenous immunoglobulin (IVIG) can prevent bacterial infections in lung transplant patients with low serum levels of immunoglobulin.
Timeline
- Start
- 2005-06
- Primary completion
- 2009-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | 400 mg/kg | Intravenous |